The Food and Drug Administration approved the abbreviated new drug application for Teligent Inc.'s (Nasdaq: TLGT) Clobetasol Propionate Cream USP, 0.05% lifting the stock price 50 cents to close at $3.52.
FDA approves Teligent's ANDA
April 18, 2018 at 16:48 PM EDT